Streetbeat News

Revenues

VST

Vistra (NYSE:VST) has significantly outperformed the market over the past 5 years, with an annualized return of 37.06%. A $100 investment in VST 5 years ago would now be worth $481.51. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 5:00 pm

SPSC

SPS Commerce (NASDAQ:SPSC) has significantly outperformed the market over the past 5 years, with an annualized return of 32.05%. A $1000 investment in SPSC 5 years ago would now be worth approximately $4005, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 5:00 pm

FTRE

Fortrea Holdings (NASDAQ:FTRE) has received mixed analyst ratings over the past three months, with a decline in average price targets. Analysts have lowered their ratings and price targets, reflecting concerns about the company's financial performance, including a revenue decline and below-average ROE and ROA. Despite these challenges, Fortrea maintains a strong net margin and a sound debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 5:00 pm

MC

Seven analysts have provided ratings for Moelis (NYSE:MC) over the past three months, showing a range of sentiments from indifferent to bearish. The average 12-month price target has increased by 10.85% to $59.86. Analysts have adjusted their ratings and price targets, reflecting evolving market conditions and company performance. Moelis has shown a positive revenue trend with a 47.1% growth rate, but faces challenges with net margin and return on equity.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 5:00 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, expresses optimism about the cannabis industry's future, highlighting Florida as a significant growth catalyst. He acknowledges risks and emphasizes understanding market dynamics as crucial for navigating the current environment.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 4:52 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, highlights the growth potential in the European cannabis market, which is expanding at 20% QoQ. Despite being smaller, the European market is growing faster than the US, with a stricter regulatory environment. Hemp is gaining traction in this bifurcated market.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 4:44 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, discusses the company's international strategy, highlighting slower consumer habits and market similarities between Germany and California. The UK market is described as pharmaceutical, while Poland resembles Germany. Curaleaf has been working in Turkey, leveraging its hemp industry knowledge.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 4:42 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, highlights the company's growth in Europe, expecting over $100 million in revenue with significant margin improvements. Curaleaf is also a major player in the US, particularly in Arizona and Florida.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 4:40 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, discussed the impact of a hurricane on their operations in Florida, including store closures and ongoing construction. The company is tripling its capacity in Florida for adult use and prioritizing safety. Pre-storm performance was strong.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 4:37 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, highlights challenges in the cannabis industry, including a recession in the consumer sector, inflation, hemp market proliferation, and lack of capital markets, which are pressuring the regulated market.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 4:35 pm